Secondary outcomes
confusion, myalgia, sleep disorder, anxiety, vertigo, aggression, dizziness, memory impairment, headache, depression, distorted taste and smell
SECONDARY
The secondary outcome was the presence of other PCS neuropsychological manifestations which were also evaluated 12 weeks after enrollment. Patients were examined for symptoms including headache, vertigo, confusion, memory impairment, poor concentration, sleep disorder, aggression, anxiety, depression, myalgia, distorted taste and smell, and dizziness [